Literature DB >> 21376230

Hallmarks of cancer: the next generation.

Douglas Hanahan1, Robert A Weinberg.   

Abstract

The hallmarks of cancer comprise six biological capabilities acquired during the multistep development of human tumors. The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease. They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis. Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions. Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metabolism and evading immune destruction. In addition to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment." Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21376230     DOI: 10.1016/j.cell.2011.02.013

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  2000 in total

1.  Centromere-associated protein E expresses a novel mRNA isoform in acute lymphoblastic leukemia.

Authors:  Cindy E Jiménez-Ávila; Vanessa Villegas-Ruíz; Marta Zapata-Tarres; Alejandra E Rubio-Portillo; Eleazar I Pérez López; Juan C Zenteno; Sergio Juárez-Méndez
Journal:  Int J Mol Epidemiol Genet       Date:  2018-10-20

2.  A marginal anticancer effect of regorafenib on pancreatic carcinoma cells in vitro, ex vivo, and in vivo.

Authors:  Barbara Mayer; Svetlana Karakhanova; Nathalie Bauer; Li Liu; Yifan Zhu; Pavel P Philippov; Jens Werner; Alexandr V Bazhin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-08-04       Impact factor: 3.000

3.  Borrowing strength: a likelihood ratio test for related sparse signals.

Authors:  Ernst C Wit; David J G Bakewell
Journal:  Bioinformatics       Date:  2012-06-04       Impact factor: 6.937

4.  Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity.

Authors:  Youngmi Kim; Eunhee Kim; Qiulian Wu; Olga Guryanova; Masahiro Hitomi; Justin D Lathia; David Serwanski; Andrew E Sloan; Robert J Weil; Jeongwu Lee; Akiko Nishiyama; Shideng Bao; Anita B Hjelmeland; Jeremy N Rich
Journal:  Genes Dev       Date:  2012-06-01       Impact factor: 11.361

5.  Quantitative, simultaneous PET/MRI for intratumoral imaging with an MRI-compatible PET scanner.

Authors:  Thomas S C Ng; James R Bading; Ryan Park; Hargun Sohi; Daniel Procissi; David Colcher; Peter S Conti; Simon R Cherry; Andrew A Raubitschek; Russell E Jacobs
Journal:  J Nucl Med       Date:  2012-06-01       Impact factor: 10.057

6.  FBXO4 inhibits lung cancer cell survival by targeting Mcl-1 for degradation.

Authors:  C Feng; F Yang; J Wang
Journal:  Cancer Gene Ther       Date:  2017-08-04       Impact factor: 5.987

7.  Sex as a Biologic Variable in Preclinical Imaging Research: Initial Observations with 18F-FLT.

Authors:  Szeman Ruby Chan; Kelley Salem; Justin Jeffery; Ginny L Powers; Yongjun Yan; Kooresh I Shoghi; Aparna M Mahajan; Amy M Fowler
Journal:  J Nucl Med       Date:  2017-12-07       Impact factor: 10.057

8.  Long non-coding RNA HOTAIR enhances angiogenesis by induction of VEGFA expression in glioma cells and transmission to endothelial cells via glioma cell derived-extracellular vesicles.

Authors:  Xin Ma; Zhaohui Li; Ting Li; Linwensi Zhu; Zhenshengnan Li; Nan Tian
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

Review 9.  Modulating secreted components of tumor microenvironment: A masterstroke in tumor therapeutics.

Authors:  Himadri Patel; Pritish Nilendu; Devashree Jahagirdar; Jayanta K Pal; Nilesh Kumar Sharma
Journal:  Cancer Biol Ther       Date:  2017-12-08       Impact factor: 4.742

10.  Tumor-Associated Mutations in Caspase-6 Negatively Impact Catalytic Efficiency.

Authors:  Kevin B Dagbay; Maureen E Hill; Elizabeth Barrett; Jeanne A Hardy
Journal:  Biochemistry       Date:  2017-08-16       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.